Global High Throughput Screening (HTS) Market 2018-2022
出 版 商：Technavio
出版日期：2018/07/11
頁 數：120頁
文件格式：PDF
價 格：
USD 2,500 (Single-User License)
USD 3,000 (Multi-User License)
USD 4,000 (Global-User License)
USD 3,000 (Multi-User License)
USD 4,000 (Global-User License)
About High Throughput Screening (HTS)
HTS is a technique employed for the evaluation and screening of a large number of biological modulators and effectors, against a selected target, during drug discovery and development.
Technavio’s analysts forecast the global high throughput screening (HTS) market to grow at a CAGR of 7.01% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global high throughput screening (HTS) market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
‧ Americas
‧ APAC
‧ EMEA
Technavio's report, Global High Throughput Screening (HTS) Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
‧ Agilent Technologies
‧ Bio-Rad Laboratories
‧ Charles River
‧ Merck KGaA
‧ PerkinElmer
‧ Thermo Fisher Scientific
Market driver
‧ Rise in R&D investments
‧ For a full, detailed list, view our report
Market challenge
‧ Shortage of trained professionals
‧ For a full, detailed list, view our report
Market trend
‧ Increasing focus on promotional activities
‧ For a full, detailed list, view our report
Key questions answered in this report
‧ What will the market size be in 2022 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
HTS is a technique employed for the evaluation and screening of a large number of biological modulators and effectors, against a selected target, during drug discovery and development.
Technavio’s analysts forecast the global high throughput screening (HTS) market to grow at a CAGR of 7.01% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global high throughput screening (HTS) market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
‧ Americas
‧ APAC
‧ EMEA
Technavio's report, Global High Throughput Screening (HTS) Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
‧ Agilent Technologies
‧ Bio-Rad Laboratories
‧ Charles River
‧ Merck KGaA
‧ PerkinElmer
‧ Thermo Fisher Scientific
Market driver
‧ Rise in R&D investments
‧ For a full, detailed list, view our report
Market challenge
‧ Shortage of trained professionals
‧ For a full, detailed list, view our report
Market trend
‧ Increasing focus on promotional activities
‧ For a full, detailed list, view our report
Key questions answered in this report
‧ What will the market size be in 2022 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
‧ Market ecosystem
‧ Market characteristics
‧ Market segmentation analysis
PART 05: MARKET SIZING
‧ Market definition
‧ Market sizing 2017
‧ Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
‧ Bargaining power of buyers
‧ Bargaining power of suppliers
‧ Threat of new entrants
‧ Threat of substitutes
‧ Threat of rivalry
‧ Market condition
PART 07: MARKET SEGMENTATION BY END-USER
‧ Segmentation by end-user
‧ Comparison by end-user
‧ Pharmaceutical and biotechnology companies – Market size and forecast 2017-2022
‧ Academic and research institutes – Market size and forecast 2017-2022
‧ CROs – Market size and forecast 2017-2022
‧ Market opportunity by end-user
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
‧ Geographical segmentation
‧ Regional comparison
‧ Americas – Market size and forecast 2017-2022
‧ EMEA – Market size and forecast 2017-2022
‧ APAC – Market size and forecast 2017-2022
‧ Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
‧ Market drivers
‧ Market challenges
PART 12: MARKET TRENDS
‧ Increasing focus on promotional activities
‧ Growth in outsourcing activities
‧ Increasing research activities in stem cells
‧ Technological advances
PART 13: VENDOR LANDSCAPE
‧ Overview
‧ Landscape disruption
PART 14: VENDOR ANALYSIS
‧ Vendors covered
‧ Vendor classification
‧ Market positioning of vendors
‧ Agilent Technologies
‧ Bio-Rad Laboratories
‧ Charles River
‧ Merck KGaA
‧ PerkinElmer
‧ Thermo Fisher Scientific
PART 15: APPENDIX
‧ List of abbreviations
Exhibit 01: Parent market
Exhibit 02: Global pharmaceutical market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global HTS market – Market size and forecast 2017-2022 ($ bn)
Exhibit 09: Global HTS market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: End-user – Market share 2017-2022 (%)
Exhibit 19: Comparison by end-user
Exhibit 20: Pharmaceutical and biotechnology companies – Market size and forecast 2017-2022 ($ bn)
Exhibit 21: Pharmaceutical and biotechnology companies – Year-over-year growth 2018-2022 (%)
Exhibit 22: Academic and research institutes – Market size and forecast 2017-2022 ($ bn)
Exhibit 23: Academic and research institutes – Year-over-year growth 2018-2022 (%)
Exhibit 24: CROs – Market size and forecast 2017-2022 ($ bn)
Exhibit 25: CROs – Year-over-year growth 2018-2022 (%)
Exhibit 26: Market opportunity by end-user
Exhibit 27: Customer landscape
Exhibit 28: Global HTS market – Market share by geography 2017-2022 (%)
Exhibit 29: Regional comparison
Exhibit 30: Americas – Market size and forecast 2017-2022 ($ bn)
Exhibit 31: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 32: Top 3 countries in Americas
Exhibit 33: EMEA – Market size and forecast 2017-2022 ($ bn)
Exhibit 34: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 35: Top 3 countries in EMEA
Exhibit 36: APAC – Market size and forecast 2017-2022 ($ bn)
Exhibit 37: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 38: Top 3 countries in APAC
Exhibit 39: Market opportunity
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Agilent Technologies overview
Exhibit 46: Agilent Technologies – Business segments
Exhibit 47: Agilent Technologies – Organizational developments
Exhibit 48: Agilent Technologies – Geographic focus
Exhibit 49: Agilent Technologies – Segment focus
Exhibit 50: Agilent Technologies – Key offerings
Exhibit 51: Bio-Rad Laboratories overview
Exhibit 52: Bio-Rad Laboratories – Business segments
Exhibit 53: Bio-Rad Laboratories – Organizational developments
Exhibit 54: Bio-Rad Laboratories – Geographic focus
Exhibit 55: Bio-Rad Laboratories – Segment focus
Exhibit 56: Bio-Rad Laboratories – Key offerings
Exhibit 57: Charles River overview
Exhibit 58: Charles River – Business segments
Exhibit 59: Charles River– Organizational developments
Exhibit 60: Charles River – Geographic focus
Exhibit 61: Charles River – Segment focus
Exhibit 62: Charles River – Key offerings
Exhibit 63: Merck KGaA overview
Exhibit 64: Merck KGaA – Business segments
Exhibit 65: Merck KGaA – Organizational developments
Exhibit 66: Merck KGaA – Geographic focus
Exhibit 67: Merck KGaA – Segment focus
Exhibit 68: Merck KGaA – Key offerings
Exhibit 69: PerkinElmer overview
Exhibit 70: PerkinElmer – Business segments
Exhibit 71: PerkinElmer – Organizational developments
Exhibit 72: PerkinElmer – Geographic focus
Exhibit 73: PerkinElmer – Segment focus
Exhibit 74: PerkinElmer – Key offerings
Exhibit 75: Thermo Fisher Scientific overview
Exhibit 76: Thermo Fisher Scientific – Business segments
Exhibit 77: Thermo Fisher Scientific – Organizational developments
Exhibit 78: Thermo Fisher Scientific – Geographic focus
Exhibit 79: Thermo Fisher Scientific – Segment focus
Exhibit 80: Thermo Fisher Scientific – Key offerings
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
‧ Market ecosystem
‧ Market characteristics
‧ Market segmentation analysis
PART 05: MARKET SIZING
‧ Market definition
‧ Market sizing 2017
‧ Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
‧ Bargaining power of buyers
‧ Bargaining power of suppliers
‧ Threat of new entrants
‧ Threat of substitutes
‧ Threat of rivalry
‧ Market condition
PART 07: MARKET SEGMENTATION BY END-USER
‧ Segmentation by end-user
‧ Comparison by end-user
‧ Pharmaceutical and biotechnology companies – Market size and forecast 2017-2022
‧ Academic and research institutes – Market size and forecast 2017-2022
‧ CROs – Market size and forecast 2017-2022
‧ Market opportunity by end-user
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
‧ Geographical segmentation
‧ Regional comparison
‧ Americas – Market size and forecast 2017-2022
‧ EMEA – Market size and forecast 2017-2022
‧ APAC – Market size and forecast 2017-2022
‧ Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
‧ Market drivers
‧ Market challenges
PART 12: MARKET TRENDS
‧ Increasing focus on promotional activities
‧ Growth in outsourcing activities
‧ Increasing research activities in stem cells
‧ Technological advances
PART 13: VENDOR LANDSCAPE
‧ Overview
‧ Landscape disruption
PART 14: VENDOR ANALYSIS
‧ Vendors covered
‧ Vendor classification
‧ Market positioning of vendors
‧ Agilent Technologies
‧ Bio-Rad Laboratories
‧ Charles River
‧ Merck KGaA
‧ PerkinElmer
‧ Thermo Fisher Scientific
PART 15: APPENDIX
‧ List of abbreviations
Exhibit 01: Parent market
Exhibit 02: Global pharmaceutical market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global HTS market – Market size and forecast 2017-2022 ($ bn)
Exhibit 09: Global HTS market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: End-user – Market share 2017-2022 (%)
Exhibit 19: Comparison by end-user
Exhibit 20: Pharmaceutical and biotechnology companies – Market size and forecast 2017-2022 ($ bn)
Exhibit 21: Pharmaceutical and biotechnology companies – Year-over-year growth 2018-2022 (%)
Exhibit 22: Academic and research institutes – Market size and forecast 2017-2022 ($ bn)
Exhibit 23: Academic and research institutes – Year-over-year growth 2018-2022 (%)
Exhibit 24: CROs – Market size and forecast 2017-2022 ($ bn)
Exhibit 25: CROs – Year-over-year growth 2018-2022 (%)
Exhibit 26: Market opportunity by end-user
Exhibit 27: Customer landscape
Exhibit 28: Global HTS market – Market share by geography 2017-2022 (%)
Exhibit 29: Regional comparison
Exhibit 30: Americas – Market size and forecast 2017-2022 ($ bn)
Exhibit 31: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 32: Top 3 countries in Americas
Exhibit 33: EMEA – Market size and forecast 2017-2022 ($ bn)
Exhibit 34: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 35: Top 3 countries in EMEA
Exhibit 36: APAC – Market size and forecast 2017-2022 ($ bn)
Exhibit 37: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 38: Top 3 countries in APAC
Exhibit 39: Market opportunity
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Agilent Technologies overview
Exhibit 46: Agilent Technologies – Business segments
Exhibit 47: Agilent Technologies – Organizational developments
Exhibit 48: Agilent Technologies – Geographic focus
Exhibit 49: Agilent Technologies – Segment focus
Exhibit 50: Agilent Technologies – Key offerings
Exhibit 51: Bio-Rad Laboratories overview
Exhibit 52: Bio-Rad Laboratories – Business segments
Exhibit 53: Bio-Rad Laboratories – Organizational developments
Exhibit 54: Bio-Rad Laboratories – Geographic focus
Exhibit 55: Bio-Rad Laboratories – Segment focus
Exhibit 56: Bio-Rad Laboratories – Key offerings
Exhibit 57: Charles River overview
Exhibit 58: Charles River – Business segments
Exhibit 59: Charles River– Organizational developments
Exhibit 60: Charles River – Geographic focus
Exhibit 61: Charles River – Segment focus
Exhibit 62: Charles River – Key offerings
Exhibit 63: Merck KGaA overview
Exhibit 64: Merck KGaA – Business segments
Exhibit 65: Merck KGaA – Organizational developments
Exhibit 66: Merck KGaA – Geographic focus
Exhibit 67: Merck KGaA – Segment focus
Exhibit 68: Merck KGaA – Key offerings
Exhibit 69: PerkinElmer overview
Exhibit 70: PerkinElmer – Business segments
Exhibit 71: PerkinElmer – Organizational developments
Exhibit 72: PerkinElmer – Geographic focus
Exhibit 73: PerkinElmer – Segment focus
Exhibit 74: PerkinElmer – Key offerings
Exhibit 75: Thermo Fisher Scientific overview
Exhibit 76: Thermo Fisher Scientific – Business segments
Exhibit 77: Thermo Fisher Scientific – Organizational developments
Exhibit 78: Thermo Fisher Scientific – Geographic focus
Exhibit 79: Thermo Fisher Scientific – Segment focus
Exhibit 80: Thermo Fisher Scientific – Key offerings
